The World Health Organization's Technical Advisory Group recommended on Wednesday that India's coronavirus vaccine COVAXIN should be granted emergency use listing status, APA reports citing Teletrader.
The Indian first homegrown COVID-19 vaccine was developed by domestic company Bharat Biotech in collaboration with the country's Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
The two-dose vaccine has estimated to be 77.8% effective in preventing COVID-19 and 93.4% successful in preventing severe cases of coronavirus infection. The latest studies also determined the jab's efficacy versus the Delta strain at 65.2%.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
